Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Functional evaluation of dynamic orthoses versus Botulinumtoxin-A in infantile cerebral palsy
2013-002896-17Phase 4Completed
- Sponsor
- Orthopedic Hospital Speising
- Start
- Oct 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of botulinum toxin type A in cerebral palsy (CP) (2 arms), sponsored by Orthopedic Hospital Speising. Primary endpoint: Flat foot or heel contact during initial contact in gait. Started Oct 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on 2013-002896-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002896-17.